Supports

Topline Phase 2 Data Supports Favorable Efficacy, Tolerability, and Safety of PTSD Treatment

by
Topline Phase 2 Data Supports Favorable Efficacy, Tolerability, and Safety of PTSD Treatment

Vitalii Vodolazskyi_AdobeStock A phase 2a study of a treatment for post-traumatic stress disorder (PTSD) and major depressive disorder (MDD) found evidence of favorable efficacy, tolerability, and safety in its PTSD cohort. The study is an ongoing, first-of-its-kind, 8-week, open-label, phase 2 validation dataset-controlled clinical trial with the aim of finding biologically based data to define … Read more

Study Supports Long-Term Efficacy of Esketamine Nasal Spray in Patients with ESRD

by
Study Supports Long-Term Efficacy of Esketamine Nasal Spray in Patients with ESRD

CONFERENCE REPORTER Results from a recent study showed that flexible-dosing esketamine nasal spray demonstrated sustained improvements in depressive symptoms in adults with treatment-resistant depression (TRD) for up to 6.5 years. Study investigators shared these results in a poster presentation at Psych Congress 2023. The poster presentation, titled Long-Term Efficacy of Esketamine Nasal Spray Dosed According … Read more